Abstract
To evaluate the effect of expression of latent membrane protein (LMP) 1 encoded by
Epstein-Barr virus (EBV) on C
To evaluate the effect of expression of latent membrane protein (LMP) 1 encoded by
Epstein-Barr virus (EBV) on C
I L Strannegard and O Strannegard, “Epstein-Barr virus antibodies in children with atopic disease,” International Archives of Allergy and Applied Immunology, vol. 64, no. 3, pp. 314–319, 1981.
View at: Google ScholarI Rystedt, I-L Strannegard, and O Strannegard, “Increased serum levels of antibodies to Epstein-Barr virus in adults with history of atopic dermatitis,” International Archives of Allergy and Applied Immunology, vol. 75, no. 2, pp. 179–183, 1984.
View at: Google ScholarG Thyphronitis, G C Tsokos, C H June, A D Levine, and F D Finkelman, “IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon ,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 14, pp. 5580–5584, 1989.
View at: Publisher Site | Google ScholarC L King, G Thyphronitis, and T B Nutman, “Enumeration of IgE secreting B cells. A filter spot-ELISA,” Journal of Immunological Methods, vol. 132, no. 1, pp. 37–43, 1990.
View at: Publisher Site | Google ScholarK O Gudmundsson, L Thorsteinsson, S Gudmundsson, and Á Haraldsson, “Immunoglobulin-secreting cells in cord blood: effects of Epstein-Barr virus and interleukin-4,” Scandinavian Journal of Immunology, vol. 50, no. 1, pp. 21–24, 1999.
View at: Publisher Site | Google ScholarS L Bahna, C A Horwitz, M Fiala, and D C Heiner, “IgE response in heterophil-positive infectious mononucleosis,” Journal of Allergy and Clinical Immunology, vol. 62, no. 3, pp. 167–173, 1978.
View at: Publisher Site | Google ScholarM Calvani, C Alessandri, G Paolone, L Rosengard, A Di Caro, and D De Franco, “Correlation between Epstein Barr virus antibodies, serum IgE and atopic disease,” Pediatric Allergy and Immunology, vol. 8, no. 2, pp. 91–96, 1997.
View at: Google ScholarJ-D Lay, C-J Tsao, J-Y Chen, M E Kadin, and I-J Su, “Upregulation of tumor necrosis factor- gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome,” Journal of Clinical Investigation, vol. 100, no. 8, pp. 1969–1979, 1997.
View at: Google ScholarB He, N Raab-Traub, P Casali, and A Cerutti, “EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching,” Journal of Immunology, vol. 171, no. 10, pp. 5215–5224, 2003.
View at: Google ScholarL S Young, C W Dawson, and A G Eliopoulos, “The expression and function of Epstein-Barr virus encoded latent genes,” Journal of Clinical Pathology: Molecular Pathology, vol. 53, no. 5, pp. 238–247, 2000.
View at: Publisher Site | Google ScholarK R Baumforth, L S Young, K J Flavell, C Constandinou, and P G Murray, “The Epstein-Barr virus and its association with human cancers,” Journal of Clinical Pathology: Molecular Pathology, vol. 52, no. 6, pp. 307–322, 1999.
View at: Google ScholarY Yanagihara, “Regulatory mechanisms of human IgE synthesis,” Allergology International, vol. 52, no. 1, pp. 1–12, 2003.
View at: Publisher Site | Google ScholarK Hanashiro, M Nakamura, N Tamaki, and T Kosugi, “Production of a monoclonal dinitrophenyl-specific rat IgE and establishment of an IgE capture ELISA for estimating the concentration of rat IgE antibodies to dinitrophenyl-Ascaris suum,” International Archives of Allergy and Immunology, vol. 110, no. 4, pp. 371–379, 1996.
View at: Google ScholarN Tamaki, K Hanashiro, S Saitoh, M Nakamura, and T Kosugi, “Evaluation of airway responses by measurement of the respiratory resistance in rats under nonanesthetized conditions,” Journal of Japan Bronchoesophagology Society, vol. 46, pp. 464–475, 1995.
View at: Google ScholarT Nakasone, K Hanashiro, M Nakamura, H Sunakawa, and T Kosugi, “An improved method for the detection of IgE FE-3 by ELISA using monoclonal anti-IgE FE-3 antibody,” Ryukyu Medical Journal, vol. 20, pp. 129–135, 2001.
View at: Google ScholarY Tokeshi, S Shimada, K Hanashiro, M Sunagawa, M Nakamura, and T Kosugi, “The nucleotide sequence of dinitrophenyl-specific IgE and FcRI -subunit obtained from FE-3 hybridoma cells,” Hybridoma and Hybridomics, vol. 20, no. 5-6, pp. 361–368, 2001.
View at: Publisher Site | Google ScholarG J Babcock and D A Thorley-Lawson, “Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 22, pp. 12250–12255, 2000.
View at: Publisher Site | Google ScholarD J Hilton, J-G Zhang, D Metcalf, W S Alexander, N A Nicola, and T A Willson, “Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 1, pp. 497–501, 1996.
View at: Publisher Site | Google ScholarD J Matthews, P A Clark, J Herbert et al., “Function of the interleukin-2 (IL-2) receptor -chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15,” Blood, vol. 85, no. 1, pp. 38–42, 1995.
View at: Google ScholarC P Thienes, L De Monte, S Monticelli, M Busslinger, H J Gould, and D Vercelli, “The transcription factor B cell-specific activator protein (BSAP) enhances both IL-4- and CD40-mediated activation of the human germline promoter,” Journal of Immunology, vol. 158, no. 12, pp. 5874–5882, 1997.
View at: Google ScholarT Mikita, M Kurama, and U Schindler, “Synergistic activation of the germline promoter mediated by Stat6 and C/EBP,” Journal of Immunology, vol. 161, no. 4, pp. 1822–1828, 1998.
View at: Google ScholarA M Stutz and M Woisetschläger, “Functional synergism of STAT6 with either NF-B or PU.1 to mediate IL- 4-induced activation of IgE germline gene transcription,” Journal of Immunology, vol. 163, no. 8, pp. 4383–4391, 1999.
View at: Google ScholarC-S Mao and J Stavnezer, “Differential regulation of mouse germline Ig 1 and promoters by IL-4 and CD40,” Journal of Immunology, vol. 167, no. 3, pp. 1522–1534, 2001.
View at: Google ScholarC-H Shen and J Stavnezer, “Activation of the mouse Ig germline promoter by IL-4 is dependent on AP-1 transcription factors,” Journal of Immunology, vol. 166, no. 1, pp. 411–423, 2001.
View at: Google ScholarS H Hanissian and R S Geha, “Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells,” Immunity, vol. 6, no. 4, pp. 379–387, 1997.
View at: Publisher Site | Google ScholarF Dedeoglu, B Horwitz, J Chaudhuri, F W Alt, and R S Geha, “Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFB,” International Immunology, vol. 16, no. 3, pp. 395–404, 2004.
View at: Publisher Site | Google ScholarH C Oettgen and R S Geha, “IgE regulation and roles in asthma pathogenesis,” Journal of Allergy and Clinical Immunology, vol. 107, no. 3, pp. 429–440, 2001.
View at: Publisher Site | Google ScholarM Sandberg, W Hammerschmidt, and B Sugden, “Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3,” Journal of Virology, vol. 71, no. 6, pp. 4649–4656, 1997.
View at: Google ScholarS S Pullen, H G Miller, D S Everdeen, T TA Dang, J J Crute, and M R Kehry, “CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization,” Biochemistry, vol. 37, no. 34, pp. 11836–11845, 1998.
View at: Publisher Site | Google Scholar